Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
3 other identifiers
interventional
225
1 country
1
Brief Summary
The goal of this behavioral-interventional study is to learn if the Abecedarian Approach implemented virtually for children ages 0-5 with a history of Hypoxic Ischaemic Encephalopathy (HIE) and/or premature birth produces the same effects as when administered at in-person facilities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2024
CompletedFirst Posted
Study publicly available on registry
October 16, 2024
CompletedStudy Start
First participant enrolled
June 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2030
March 27, 2026
March 1, 2026
4.7 years
October 10, 2024
March 24, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Parent Satisfaction Questionnaire
Questionnaire measuring parent satisfaction with the intervention and effects given at the end of the virtual program. Responses as measured by answering either strongly agree, agree, disagree or strongly disagree. Responses will be measured at the end of the intervention at 60 months and reported as participant counts.
Assessed at end of treatment (up to 60 months)
Number of Sessions Attended
We will be taking attendance of sessions to measure parent compliance with the virtual program. Attendance will be taken for each live session (every other week) for the entire period of enrollment (260 weeks).
Assessed biweekly from enrollment to end of treatment (up to 260 weeks)
Secondary Outcomes (6)
Bayley Assessment
Data collected at 12, 24, 36, 48, and 60 month time points
Behavior Reporting Inventory of Executive Function - Preschool Version (BRIEF-P)
Data collected at the 24, 36, 48, and 60 month time points
Pediatric Quality of Life Inventory (PedsQL)
Data collected at baseline, 24, 36, 48 and 60 month time points
Early Executive Functions Questionnaire (EEFQ)
Data collected at baseline, 12, and 24 month time points
NIH Baby/Infant and NIH Pediatric Toolbox
Data collected at 12, 24, 36, 48, and 60-month time points
- +1 more secondary outcomes
Study Arms (3)
Standard of Care Provided
NO INTERVENTIONIn the No Intervention condition, at-risk children will receive the current standard of care, and no intervention.
Virtual Abecedarian Approach Intervention
EXPERIMENTALIn the Virtual Abecedarian Approach Intervention, children will partake in the Abecedarian Approach Intervention through a virtual format.
Feasibility Group
EXPERIMENTALParticipants will be in fewer sessions in order to assess whether the intervention is accepted by the parents.
Interventions
The Abecedarian Approach is an early childhood behavioral education program that aims to improve the learning and cognitive development of children in high-risk or at-risk communities. This study will test the efficacy of implementing this approach in a virtual format.
Eligibility Criteria
You may qualify if:
- IPNH-NDCP patients, including:
- Term-born children diagnosed during the neonatal period with hypoxic-ischemic encephalopathy, or
- premature children (born at less than 28 weeks gestational age).
- Parent or legal guardian will also be enrolled as a participant
- Parents must be English-speaking (able to provide consent and complete questionnaires).
You may not qualify if:
- Not suitable for study participation due to other reasons at the discretion of the investigator.
- Infants with chromosomal abnormalities, genetic syndromes (for example, such as Down Syndrome or Trisomy18) and major congenital malformations will be excluded.
- Infants with vision impairment will also be excluded from the study, as our study procedures do require intact vision to be able to complete.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Wisconsin Madison
Madison, Wisconsin, 53715, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Melisa Carrasco McCaul, MD, PhD
University of Wisconsin, Madison
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 10, 2024
First Posted
October 16, 2024
Study Start
June 3, 2025
Primary Completion (Estimated)
March 1, 2030
Study Completion (Estimated)
March 1, 2030
Last Updated
March 27, 2026
Record last verified: 2026-03